You are here » Home » Companies » Company Overview » Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd.

BSE: 533573 Sector: Health care
NSE: APLLTD ISIN Code: INE901L01018
BSE LIVE 13:36 | 06 Dec 634.20 9.75
(1.56%)
OPEN

633.00

HIGH

636.25

LOW

630.60

NSE LIVE 13:34 | 06 Dec 634.30 10.15
(1.63%)
OPEN

630.40

HIGH

636.60

LOW

628.65

OPEN 633.00
PREVIOUS CLOSE 624.45
VOLUME 348
52-Week high 727.25
52-Week low 514.35
P/E 20.46
Mkt Cap.(Rs cr) 11954.67
Buy Price 634.00
Buy Qty 21.00
Sell Price 634.20
Sell Qty 138.00
OPEN 633.00
CLOSE 624.45
VOLUME 348
52-Week high 727.25
52-Week low 514.35
P/E 20.46
Mkt Cap.(Rs cr) 11954.67
Buy Price 634.00
Buy Qty 21.00
Sell Price 634.20
Sell Qty 138.00

About Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd was incorporated on June 16 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in Pharamceulicals business. As per the scheme of arrangement the Pharmaceutical Undertaking of the Alembic Ltd was demerged and transferred to the company with effect from appointed date April 1 2010. In April 15 2011 the company ceased to be a subsidiary of Alembic Ltd...> More

Alembic Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   11,955
EPS - TTM () [*C] 31.00
P/E Ratio (X) [*C] 20.46
Face Value ()   2
Latest Dividend (%)   200.00
Latest Dividend Date 20 Jul 2016
Dividend Yield (%) 0.64
Book Value / Share () [*C] 91.03
P/B Ratio () [*C] 6.97
[*C] Consolidated     [*S] Standalone

Alembic Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 872.25 1004.26 -13.15
Other Income 0.5 0.05 900
Total Income 872.75 1004.31 -13.1
Total Expenses 694.48 628.5 10.5
Operating Profit 178.27 375.81 -52.56
Net Profit 123.54 288.16 -57.13
Equity Capital 37.7 37.7 -
> More on Alembic Pharmaceuticals Ltd Financials Results

Alembic Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alkem Lab 1701.00 0.13 20335.45
Biocon 915.00 -0.31 18300.00
Ajanta Pharma 1874.90 -0.64 16499.12
Alembic Pharma 634.20 1.56 11954.67
Syngene Intl. 577.80 0.32 11556.00
Jubilant Life 696.35 -0.59 11092.86
Natco Pharma 597.90 1.06 10421.40
> More on Alembic Pharmaceuticals Ltd Peer Group

Alembic Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 74.35
Banks/FIs 0.32
FIIs 10.91
Insurance 0.00
Mutual Funds 2.56
Indian Public 9.94
Custodians 0.00
Other 1.92
> More on Alembic Pharmaceuticals Ltd Share Holding Pattern

Alembic Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
02/05 Nirmal Bang Hold 603 PDF IconDetails
21/01 Motilal Oswal Neutral 626 PDF IconDetails
28/10 Nirmal Bang Hold 664 PDF IconDetails
11/05 Angel Broking Neutral 479 PDF IconDetails
04/02 Motilal Oswal Buy 430 PDF IconDetails
> More on Alembic Pharmaceuticals Ltd Research Reports

Alembic Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.43% -2.44% 0.21% 0.23%
1 Month -3.30% -3.37% -3.03% -3.24%
3 Month 1.12% 1.14% -8.73% -8.75%
6 Month 13.64% 13.52% -1.23% -0.49%
1 Year -6.74% -6.91% 3.16% 4.87%
3 Year 208.39% 209.94% 25.97% 30.36%

Alembic Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 630.60
636.25
Week Low/High 616.80
672.00
Month Low/High 590.50
674.00
YEAR Low/High 514.35
727.00
All TIME Low/High 34.00
792.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard